R. Padmavathi, K. Keerthana, A. Shanmuga Sundaram Devi, Y. Hari, A. Samad
{"title":"菠萝蛋白酶与姜黄联合抗醋酸致溃疡性结肠炎的实验研究","authors":"R. Padmavathi, K. Keerthana, A. Shanmuga Sundaram Devi, Y. Hari, A. Samad","doi":"10.18231/j.joapr.2021.15.24","DOIUrl":null,"url":null,"abstract":"Objective: The present study planned to study the combined effect of Bromelain and Turmeric in acetic acid induced ulcerative colitis in Wistar rats. \nMethodology: Wistar rats of either sex (n = 30) were divided into 5 groups. Group – I, Sham control, administered single dose of vehicle rectally; Group –II, colitis control, colitis was induced by rectal administration of single dose of 2 ml of 3%, v/v of acetic acid in 0.9% saline; Group–III, treated with Turmeric (50 mg/kg/p.o); Group–IV, treated with Bromelain (100 mg/kg/p.o) and Group –V, treated with both Turmeric (50 mg/kg/p.o) and Bromelain (100 mg /kg/p.o). Colitis was induced in all the treatment groups on first day and drug treatment was continued for 7 days. During the treatment period, Disease Activity Index (DAI) was assessed daily and on 8th day White Blood Cell (WBC) Count and Differential Leucocyte Count (DLC) was performed and on 9th day all the rats were sacrificed for the assessment of intestinal inflammation, colon myeloperoxidase (MPO) levels and Histopathology. Results obtained were analysed by one-way analysis of variance followed by Tukey’s multiple comparison test. \nResults: Overall changes in DAI, Inflammatory scores, WBC, DLC and MPO has shown significant improvement with Turmeric and Bromelain compared to Colitis control. However, the combined therapy has shown to be more effective in alleviating ulcerative colitis compared to individual therapies. \nConclusion: The present study recommends that the combination of Turmeric and Bromelain has synergistic effect in treating ulcerative colitis.","PeriodicalId":15232,"journal":{"name":"Journal of Applied Pharmaceutical Research","volume":"94 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Combined effect of bromelain and turmeric against acetic acid induced ulcerative colitis in wistar rats\",\"authors\":\"R. Padmavathi, K. Keerthana, A. Shanmuga Sundaram Devi, Y. Hari, A. Samad\",\"doi\":\"10.18231/j.joapr.2021.15.24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: The present study planned to study the combined effect of Bromelain and Turmeric in acetic acid induced ulcerative colitis in Wistar rats. \\nMethodology: Wistar rats of either sex (n = 30) were divided into 5 groups. Group – I, Sham control, administered single dose of vehicle rectally; Group –II, colitis control, colitis was induced by rectal administration of single dose of 2 ml of 3%, v/v of acetic acid in 0.9% saline; Group–III, treated with Turmeric (50 mg/kg/p.o); Group–IV, treated with Bromelain (100 mg/kg/p.o) and Group –V, treated with both Turmeric (50 mg/kg/p.o) and Bromelain (100 mg /kg/p.o). Colitis was induced in all the treatment groups on first day and drug treatment was continued for 7 days. During the treatment period, Disease Activity Index (DAI) was assessed daily and on 8th day White Blood Cell (WBC) Count and Differential Leucocyte Count (DLC) was performed and on 9th day all the rats were sacrificed for the assessment of intestinal inflammation, colon myeloperoxidase (MPO) levels and Histopathology. Results obtained were analysed by one-way analysis of variance followed by Tukey’s multiple comparison test. \\nResults: Overall changes in DAI, Inflammatory scores, WBC, DLC and MPO has shown significant improvement with Turmeric and Bromelain compared to Colitis control. However, the combined therapy has shown to be more effective in alleviating ulcerative colitis compared to individual therapies. \\nConclusion: The present study recommends that the combination of Turmeric and Bromelain has synergistic effect in treating ulcerative colitis.\",\"PeriodicalId\":15232,\"journal\":{\"name\":\"Journal of Applied Pharmaceutical Research\",\"volume\":\"94 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Applied Pharmaceutical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18231/j.joapr.2021.15.24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Pharmaceutical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.joapr.2021.15.24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
目的:研究菠萝蛋白酶和姜黄对醋酸致Wistar大鼠溃疡性结肠炎的联合治疗作用。方法:Wistar大鼠各30只,随机分为5组。ⅰ组,假手术对照组,单次给药;-II组,结肠炎对照组,结肠结肠炎是在0.9%生理盐水中单次给药2 ml 3% v/v醋酸;第三组,用姜黄处理(50 mg/kg/p.o);iv组,用菠萝蛋白酶(100 mg/kg/p.o)处理;v组,用姜黄(50 mg/kg/p.o)和菠萝蛋白酶(100 mg/kg/p.o)处理。各治疗组第1天均发生结肠炎,连续用药7 d。治疗期间每日测定疾病活动指数(DAI),第8天测定白细胞(WBC)计数和白细胞差异计数(DLC),第9天处死各组大鼠,观察肠道炎症、结肠髓过氧化物酶(MPO)水平和组织病理学变化。所得结果采用单因素方差分析及Tukey多重比较检验进行分析。结果:与结肠炎对照组相比,姜黄和菠萝蛋白酶组DAI、炎症评分、WBC、DLC和MPO的总体变化显示出显著改善。然而,与单独治疗相比,联合治疗在缓解溃疡性结肠炎方面更有效。结论:本研究提示姜黄与菠萝蛋白酶联合治疗溃疡性结肠炎具有协同作用。
Combined effect of bromelain and turmeric against acetic acid induced ulcerative colitis in wistar rats
Objective: The present study planned to study the combined effect of Bromelain and Turmeric in acetic acid induced ulcerative colitis in Wistar rats.
Methodology: Wistar rats of either sex (n = 30) were divided into 5 groups. Group – I, Sham control, administered single dose of vehicle rectally; Group –II, colitis control, colitis was induced by rectal administration of single dose of 2 ml of 3%, v/v of acetic acid in 0.9% saline; Group–III, treated with Turmeric (50 mg/kg/p.o); Group–IV, treated with Bromelain (100 mg/kg/p.o) and Group –V, treated with both Turmeric (50 mg/kg/p.o) and Bromelain (100 mg /kg/p.o). Colitis was induced in all the treatment groups on first day and drug treatment was continued for 7 days. During the treatment period, Disease Activity Index (DAI) was assessed daily and on 8th day White Blood Cell (WBC) Count and Differential Leucocyte Count (DLC) was performed and on 9th day all the rats were sacrificed for the assessment of intestinal inflammation, colon myeloperoxidase (MPO) levels and Histopathology. Results obtained were analysed by one-way analysis of variance followed by Tukey’s multiple comparison test.
Results: Overall changes in DAI, Inflammatory scores, WBC, DLC and MPO has shown significant improvement with Turmeric and Bromelain compared to Colitis control. However, the combined therapy has shown to be more effective in alleviating ulcerative colitis compared to individual therapies.
Conclusion: The present study recommends that the combination of Turmeric and Bromelain has synergistic effect in treating ulcerative colitis.